Downregulation of SLC10A1 is correlated with poor survival outcome and recurrence-free survival in patients with HCC [26], but whether SLC10A1 has interaction with other regulatory factors in HCC remains unknown. This evidence concerns the gene SLC10A1 and hepatocellular carcinoma.